We&Win Diversification Co Ltd (4113) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.061x

Based on the latest financial reports, We&Win Diversification Co Ltd (4113) has a cash flow conversion efficiency ratio of -0.061x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-258.80 Million ≈ $-8.15 Million USD) by net assets (NT$4.27 Billion ≈ $134.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See We&Win Diversification Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

We&Win Diversification Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how We&Win Diversification Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check We&Win Diversification Co Ltd (4113) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

We&Win Diversification Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of We&Win Diversification Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Emvision Medical Devices Ltd
AU:EMV
-0.301x
I-Berhad
KLSE:4251
0.032x
Endomines Finland Oyj
HE:PAMPALO
0.142x
Carnaby Resources Ltd
AU:CNB
-0.074x
Themis Medicare Limited
NSE:THEMISMED
-0.004x
Ferronordic AB (publ)
ST:FNM
-0.108x
Sedana Medical AB
ST:SEDANA
-0.006x
Hillevax Inc
NASDAQ:HLVX
-0.005x

Annual Cash Flow Conversion Efficiency for We&Win Diversification Co Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of We&Win Diversification Co Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see 4113 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$4.27 Billion
≈ $134.43 Million
NT$-2.92 Billion
≈ $-91.95 Million
-0.684x -239.56%
2024-12-31 NT$4.52 Billion
≈ $142.55 Million
NT$2.22 Billion
≈ $69.87 Million
0.490x +262.79%
2023-12-31 NT$3.11 Billion
≈ $98.08 Million
NT$-937.22 Million
≈ $-29.53 Million
-0.301x +34.45%
2022-12-31 NT$3.26 Billion
≈ $102.67 Million
NT$-1.50 Billion
≈ $-47.16 Million
-0.459x -1233.09%
2021-12-31 NT$3.49 Billion
≈ $109.87 Million
NT$141.35 Million
≈ $4.45 Million
0.041x +107.33%
2020-12-31 NT$3.42 Billion
≈ $107.65 Million
NT$-1.89 Billion
≈ $-59.55 Million
-0.553x -473.46%
2019-12-31 NT$3.52 Billion
≈ $110.99 Million
NT$521.83 Million
≈ $16.44 Million
0.148x +280.99%
2018-12-31 NT$3.73 Billion
≈ $117.54 Million
NT$145.05 Million
≈ $4.57 Million
0.039x +135.02%
2017-12-31 NT$3.61 Billion
≈ $113.60 Million
NT$-400.30 Million
≈ $-12.61 Million
-0.111x --

About We&Win Diversification Co Ltd

TWO:4113 Taiwan Engineering & Construction
Market Cap
$104.86 Million
NT$3.33 Billion TWD
Market Cap Rank
#18958 Global
#1029 in Taiwan
Share Price
NT$14.40
Change (1 day)
+1.05%
52-Week Range
NT$14.10 - NT$26.05
All Time High
NT$64.90
About

We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 20… Read more